Congress Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183M | Sell |
1,701,570
-17,258
| -1% | -$1.85M | 1.25% | 16 |
|
|
2025
Q1 | $173M | Sell |
1,718,828
-3,364
| -0.2% | -$339K | 1.3% | 9 |
|
|
2024
Q4 | $154M | Buy |
1,722,192
+3,538
| +0.2% | +$316K | 1.04% | 18 |
|
|
2024
Q3 | $144M | Buy |
1,718,654
+53,346
| +3% | +$4.47M | 0.98% | 24 |
|
|
2024
Q2 | $128M | Buy |
1,665,308
+155,829
| +10% | +$12M | 0.92% | 39 |
|
|
2024
Q1 | $103M | Buy |
1,509,479
+31,615
| +2% | +$2.17M | 0.74% | 62 |
|
|
2023
Q4 | $85.4M | Buy |
1,477,864
+33,214
| +2% | +$1.92M | 0.67% | 70 |
|
|
2023
Q3 | $76.3M | Buy |
1,444,650
+1,439,830
| +29,872% | +$76M | 0.67% | 74 |
|
|
2023
Q2 | $261K | Hold |
4,820
| – | – | ﹤0.01% | 357 |
|
|
2023
Q1 | $241K | Hold |
4,820
| – | – | ﹤0.01% | 363 |
|
|
2022
Q4 | $223K | Buy |
+4,820
| New | +$223K | ﹤0.01% | 371 |
|